Allen Maynard, PA-C | |
17401 Kentucky Hwy 80 East, Elkhorn City, KY 41522-8210 | |
(606) 754-3131 | |
(606) 754-4554 |
Full Name | Allen Maynard |
---|---|
Gender | Male |
Speciality | Physician Assistant |
Location | 17401 Kentucky Hwy 80 East, Elkhorn City, Kentucky |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1134300932 | NPI | - | NPPES |
P0131826 | Other | KY | RR MEDICARE PTAN |
71000055500 | Medicaid | KY |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2081P2900X | Physical Medicine & Rehabilitation - Pain Medicine | PA953 (Kentucky) | Secondary |
363A00000X | Physician Assistant | PA953 (Kentucky) | Primary |
Mailing Address | Practice Location Address |
---|---|
Allen Maynard, PA-C 17401 Kentucky Hwy 80 East, Elkhorn City, KY 41522-8210 Ph: (606) 754-3131 | Allen Maynard, PA-C 17401 Kentucky Hwy 80 East, Elkhorn City, KY 41522-8210 Ph: (606) 754-3131 |
News Archive
Juniper Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development of therapeutics for women's health, announced today the first patient has been enrolled in a Phase II clinical trial of COL-1077, a 10% lidocaine bioadhesive gel that is intended as an acute-use anesthetic during minimally invasive gynecologic procedures.
Data presented today at a major medical meeting include findings that demonstrate improved handwriting performance in children with Attention Deficit Hyperactivity Disorder (ADHD) when taking CONCERTA® (OROS® methylphenidate HCl Extended-Release Tablets CII) compared to placebo.
The ability to discern pitch - to hear the difference between "cat," "bat" and "hat," for example - hinges on remarkable gradations in specialized cells within the inner ear.
Previous studies have indicated that surgeons receive little training in palliative surgical intervention, the objective of which is to relieve symptoms and improve quality of life rather than cure disease or extend survival, according to background information in the article.
A drug commonly used to treat cancer can restore memory and cognitive function in mice that display symptoms of Alzheimer's disease, new UBC research has found.
› Verified 7 days ago